Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma

SIMPLE SUMMARY: Ovarian cancer is commonly associated with poor survival; patients with a diagnosis of high-grade serous ovarian carcinoma (HGSC) have an overall survival of 39% at 5 years. For reasons not well known, about 32% of ovarian cancer patients survive 10 years or more. In this study, our...

Descripción completa

Detalles Bibliográficos
Autores principales: Stur, Elaine, Bayraktar, Emine, Dal Molin, Graziela Zibetti, Wu, Sherry Y., Mangala, Lingegowda S., Yao, Hui, Wang, Ying, Ram, Prahlad T., Corvigno, Sara, Chen, Hu, Liang, Han, Tworoger, Shelley S., Levine, Douglas A., Lutgendorf, Susan K., Liu, Jinsong, Moore, Kathleen N., Baggerly, Keith A., Karlan, Beth Y., Sood, Anil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454595/
https://www.ncbi.nlm.nih.gov/pubmed/36077735
http://dx.doi.org/10.3390/cancers14174198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454595/
https://www.ncbi.nlm.nih.gov/pubmed/36077735
http://dx.doi.org/10.3390/cancers14174198

Ejemplares similares